Moderna Stock

Moderna P/B

The P/B (Price-to-Book Ratio) of Moderna (MRNA) as of Jul 31, 2026 is 1.91. In the previous year, P/B (Price-to-Book Ratio) was 1.51 — a change of 26.02% (higher).

P/B

1.91

YoY

26.02%

Last updated:

P/B (Price-to-Book Ratio) of Moderna is 2026 1.91 . P/B (Price-to-Book Ratio) of Moderna was 2025 1.51 . It decreases by 26.02% higher compared to the previous year.
Access this data via the Eulerpool API

Moderna Stock analysis

What does Moderna do? Moderna Inc is a biotechnology company from the USA that specializes in the development of therapies and vaccines based on mRNA technology. The company was founded in 2010 by a group of researchers led by Noubar Afeyan and is headquartered in Cambridge, Massachusetts. Moderna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moderna stock

P/B (Price-to-Book Ratio) of Moderna is 1.91 in 2026.

Access this data via the Eulerpool API

Valuation — Moderna

All Key Metrics — Moderna